- $503.38m
- $107.72m
- 50
- 31
- 40
- 35
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30.9 | 56.2 | 80.9 | 118 | 177 |
Operating Profit | -30.9 | -56.2 | -80.9 | -118 | -177 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -30.8 | -52.6 | -80.9 | -118 | -174 |
Provision for Income Taxes | |||||
Net Income After Taxes | -30.8 | -52.6 | -80.9 | -118 | -174 |
Net Income Before Extraordinary Items | |||||
Net Income | -30.8 | -52.6 | -80.9 | -118 | -174 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -30.8 | -52.6 | -80.9 | -118 | -174 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.33 | -1.54 | -1.73 | -2.26 | -2.99 |
Dividends per Share |